KRAS and neoplasm: In univariate analysis, a high DDR1 immunostaining score was significantly associated with male sex (p = 0.0195), left tumor location (p = 0.0114), BRAF wild-type status (p < 0.0001), KRAS mutated status (p = 0.0041), and absence of expression of the serrated markers Annexin A10 (p = 0.0097).